{"id":10580,"date":"2018-06-03T05:00:41","date_gmt":"2018-06-03T09:00:41","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10580"},"modified":"2018-06-01T10:20:19","modified_gmt":"2018-06-01T14:20:19","slug":"mergers-between-health-insurers-and-pharmacy-benefit-managers-could-be-bad-for-your-health","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10580","title":{"rendered":"Mergers between health insurers and pharmacy benefit managers could be bad for your health"},"content":{"rendered":"<p>(By Barak Richman and Kevin Schulman for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">Pharmacy benefit managers, which long ran under the public radar, now have President Trump\u2019s attention. In a\u00a0<a href=\"https:\/\/www.statnews.com\/2018\/05\/11\/trump-drug-pricing-speech\/\">recent speech on drug pricing<\/a>, he called out \u201cthe dishonest double-dealing that allows the middleman to pocket rebates and discounts that should be passed on to consumers and patients.\u201d <a href=\"https:\/\/www.statnews.com\/2018\/06\/01\/mergers-health-insurers-pharmacy-benefit-managers\/\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Barak Richman and Kevin Schulman for STAT) Pharmacy benefit managers, which long ran under the public radar, now have<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,15],"tags":[],"class_list":["post-10580","post","type-post","status-publish","format-standard","hentry","category-health-care-redesign","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10580"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10580\/revisions"}],"predecessor-version":[{"id":10581,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10580\/revisions\/10581"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}